Schottenfeld-Naor Y, Galatzer A, Karp M, Josefsberg Z, Laron Z
Isr J Med Sci. 1985 Oct;21(10):822-8.
Two methods of insulin treatment--intensified conventional therapy (ICT) of three to four daily injections and continuous s.c. insulin infusion (CSII)--were compared in nine patients with insulin-dependent diabetes mellitus (mean age +/- SD 29.4 +/- 5.6 years; duration of diabetes 14.6 +/- 2.9 years). Patients followed each regimen for 3 to 4 months. Under both regimens hemoglobin A1 (HbA1) levels were lower than those recorded previously, but under CSII the mean HbA1 and glucose levels were significantly lower than under ICT (7.8 +/- 0.1 vs. 8.9 +/- 0.2% for HbA1 and 136 +/- 40 vs. 155 +/- 60 mg/dl for blood glucose, P less than 0.001). There was no difference in the frequency of blood glucose levels less than 60 mg/dl, but under CSII hypoglycemic symptoms appeared at lower glucose levels. There was no marked difference between the two regimens regarding scores for depression and anxiety and other psychological parameters, but patients who chose to continue treatment with CSII following completion of the study had previously manifested a significantly higher degree of distress symptoms, which had been reduced during the study. CSII was preferred by some patients because of the superior metabolic control achieved and the greater flexibility in time and size of meals permitted, but was rejected by others because of technical failures and bulkiness of the device. It is concluded that metabolic control can be improved by either regimen, but external pumps must be further miniaturized and technical failures eliminated before CSIII is acceptable to larger numbers of patients.
对9例胰岛素依赖型糖尿病患者(平均年龄±标准差29.4±5.6岁;糖尿病病程14.6±2.9年)比较了两种胰岛素治疗方法——每日三到四次注射的强化常规治疗(ICT)和皮下胰岛素持续输注(CSII)。患者每种治疗方案遵循3至4个月。在两种治疗方案下,糖化血红蛋白(HbA1)水平均低于之前记录的水平,但在CSII治疗下,平均HbA1和血糖水平显著低于ICT治疗(HbA1分别为7.8±0.1%对8.9±0.2%,血糖分别为136±40对155±60mg/dl,P<0.001)。血糖水平低于60mg/dl的频率没有差异,但在CSII治疗下,低血糖症状出现在更低的血糖水平时。两种治疗方案在抑郁和焦虑评分及其他心理参数方面没有显著差异,但在研究结束后选择继续使用CSII治疗的患者之前表现出显著更高程度的痛苦症状,这些症状在研究期间有所减轻。一些患者更喜欢CSII,因为其实现了更好的代谢控制,并且在进餐时间和量上具有更大的灵活性,但另一些患者则因技术故障和设备笨重而拒绝使用。结论是,两种治疗方案均可改善代谢控制,但在CSII被更多患者接受之前,外置泵必须进一步小型化并消除技术故障。